The global Immunohistochemistry Market is valued at an estimated USD 3.4 billion in 2024 and is projected to reach USD 5.2 ...

The growing demand for immune checkpoint inhibitors is mainly driven by the rising incidence of lung cancer, the increasing prevalence of melanoma, and the expanding number of research studies related ...

(Funded by F. Hoffmann–La Roche; REGENCY ClinicalTrials.gov number, NCT04221477.) A data sharing statement provided by the authors is available with the full text of this article at NEJM.org.

Report with market evolution powered by AI - The global antibiotics market size is estimated to grow by USD 18.22 billion ...

who is the great-grandson of Fritz Hoffmann-La Roche, founder of pharmaceuticals group Roche, and the noisy SpaceX creator and X owner. “The arrogance of these guys knows no limit,” grumbles ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 43 tables and 86 figures, this 160-page report ?Europe Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service ...

F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have identified new benzimidazoles acting as serine/threonine-protein kinase SIK inhibitors reported to be useful for the treatment of rheumatoid ...

Hoffmann-La Roche Limited (Roche Canada) announced that Health Canada has authorized Vabysmo (faricimab injection) for use in a 6.0 mg single-use pre-filled syringe (PFS) for use in the treatment of ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 39 tables and 61 figures, this 133-page report Europe Bioprocess Technology Market 2023-2033 by Product (Instruments, ...